What is scope of the report?

The base year for the study has been considered 2019, historic year 2014 and 2018. Read More

What are the significant segments operating in the market?

Market is segmented on the basis. Read More

What are the vital market dynamics?

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. Read More

What does a company profile includes?

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering. Read More

Global Contraceptives Drugs and Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

Publish Date: Mar, 2020
Report ID: 412595
Category: Medical Devices
Pages: 109

$3480

Market Overview

The global Contraceptives Drugs and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.5% in the forecast period of 2020 to 2025 and will expected to reach USD 24150 million by 2025, from USD 18110 million in 2019.

The Contraceptives Drugs and Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Contraceptives Drugs and Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Contraceptives Drugs and Devices market has been segmented into

Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)

Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

By Application, Contraceptives Drugs and Devices has been segmented into:

Female

Male

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Contraceptives Drugs and Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Contraceptives Drugs and Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Contraceptives Drugs and Devices market.

The report offers in-depth assessment of the growth and other aspects of the Contraceptives Drugs and Devices market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, etc.)

Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Contraceptives Drugs and Devices Market Share Analysis

Contraceptives Drugs and Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Contraceptives Drugs and Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Contraceptives Drugs and Devices sales, revenue and market share for each player covered in this report.

The major players covered in Contraceptives Drugs and Devices are:

Teva Pharmaceutical Industries Ltd

Cooper Surgical, Inc

Pfizer, Inc

Church & Dwight Co. Inc

The Female Health Company

Reckitt Benckiser Plc

Cipla Limited

Mayer Laboratories, Inc

Bayer AG

Allergan plc

Merck & Co. Inc

Among other players domestic and global, Contraceptives Drugs and Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Contraceptives Drugs and Devices product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Contraceptives Drugs and Devices, with price, sales, revenue and global market share of Contraceptives Drugs and Devices in 2018 and 2019.

Chapter 3, the Contraceptives Drugs and Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Contraceptives Drugs and Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 12, Contraceptives Drugs and Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.

Chapter 13, 14 and 15, to describe Contraceptives Drugs and Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Request Sample Request for Customization

Table of Contents

1 Market Overview

1.1 Contraceptives Drugs and Devices Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Contraceptives Drugs and Devices Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)

1.2.3 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

1.3 Market Analysis by Application

1.3.1 Overview: Global Contraceptives Drugs and Devices Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Female

1.3.3 Male

1.4 Overview of Global Contraceptives Drugs and Devices Market

1.4.1 Global Contraceptives Drugs and Devices Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Teva Pharmaceutical Industries Ltd

2.1.1 Teva Pharmaceutical Industries Ltd Details

2.1.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Teva Pharmaceutical Industries Ltd SWOT Analysis

2.1.4 Teva Pharmaceutical Industries Ltd Product and Services

2.1.5 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Cooper Surgical, Inc

2.2.1 Cooper Surgical, Inc Details

2.2.2 Cooper Surgical, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Cooper Surgical, Inc SWOT Analysis

2.2.4 Cooper Surgical, Inc Product and Services

2.2.5 Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Pfizer, Inc

2.3.1 Pfizer, Inc Details

2.3.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Pfizer, Inc SWOT Analysis

2.3.4 Pfizer, Inc Product and Services

2.3.5 Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Church & Dwight Co. Inc

2.4.1 Church & Dwight Co. Inc Details

2.4.2 Church & Dwight Co. Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Church & Dwight Co. Inc SWOT Analysis

2.4.4 Church & Dwight Co. Inc Product and Services

2.4.5 Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 The Female Health Company

2.5.1 The Female Health Company Details

2.5.2 The Female Health Company Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 The Female Health Company SWOT Analysis

2.5.4 The Female Health Company Product and Services

2.5.5 The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Reckitt Benckiser Plc

2.6.1 Reckitt Benckiser Plc Details

2.6.2 Reckitt Benckiser Plc Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Reckitt Benckiser Plc SWOT Analysis

2.6.4 Reckitt Benckiser Plc Product and Services

2.6.5 Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Cipla Limited

2.7.1 Cipla Limited Details

2.7.2 Cipla Limited Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Cipla Limited SWOT Analysis

2.7.4 Cipla Limited Product and Services

2.7.5 Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Mayer Laboratories, Inc

2.8.1 Mayer Laboratories, Inc Details

2.8.2 Mayer Laboratories, Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Mayer Laboratories, Inc SWOT Analysis

2.8.4 Mayer Laboratories, Inc Product and Services

2.8.5 Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Bayer AG

2.9.1 Bayer AG Details

2.9.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Bayer AG SWOT Analysis

2.9.4 Bayer AG Product and Services

2.9.5 Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 Allergan plc

2.10.1 Allergan plc Details

2.10.2 Allergan plc Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Allergan plc SWOT Analysis

2.10.4 Allergan plc Product and Services

2.10.5 Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Merck & Co. Inc

2.11.1 Merck & Co. Inc Details

2.11.2 Merck & Co. Inc Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Merck & Co. Inc SWOT Analysis

2.11.4 Merck & Co. Inc Product and Services

2.11.5 Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Contraceptives Drugs and Devices Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Contraceptives Drugs and Devices Manufacturer Market Share in 2019

3.3.2 Top 6 Contraceptives Drugs and Devices Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Contraceptives Drugs and Devices Sales, Revenue and Market Share by Regions

4.1.1 Global Contraceptives Drugs and Devices Sales and Market Share by Regions (2015-2020)

4.1.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Regions (2015-2020)

4.2 North America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

4.3 Europe Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

4.5 South America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country

5.1.1 North America Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)

5.1.2 North America Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)

5.2 United States Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

5.3 Canada Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

5.4 Mexico Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country

6.1.1 Europe Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)

6.1.2 Europe Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)

6.2 Germany Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

6.3 UK Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

6.4 France Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

6.5 Russia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

6.6 Italy Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Contraceptives Drugs and Devices Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Contraceptives Drugs and Devices Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Contraceptives Drugs and Devices Revenue and Market Share by Regions (2015-2020)

7.2 China Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

7.3 Japan Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

7.4 Korea Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

7.5 India Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

7.7 Australia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country

8.1.1 South America Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)

8.1.2 South America Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)

8.2 Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

8.3 Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Contraceptives Drugs and Devices Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Contraceptives Drugs and Devices Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Contraceptives Drugs and Devices Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

9.3 Turkey Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

9.4 Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

9.5 South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Contraceptives Drugs and Devices Sales and Market Share by Type (2015-2020)

10.2 Global Contraceptives Drugs and Devices Revenue and Market Share by Type (2015-2020)

10.3 Global Contraceptives Drugs and Devices Price by Type (2015-2020)

11 Global Contraceptives Drugs and Devices Market Segment by Application

11.1 Global Contraceptives Drugs and Devices Sales Market Share by Application (2015-2020)

11.2 Global Contraceptives Drugs and Devices Revenue Market Share by Application (2015-2020)

11.3 Global Contraceptives Drugs and Devices Price by Application (2015-2020)

12 Market Forecast

12.1 Global Contraceptives Drugs and Devices Sales, Revenue and Growth Rate (2021-2025)

12.2 Contraceptives Drugs and Devices Market Forecast by Regions (2021-2025)

12.2.1 North America Contraceptives Drugs and Devices Market Forecast (2021-2025)

12.2.2 Europe Contraceptives Drugs and Devices Market Forecast (2021-2025)

12.2.3 Asia-Pacific Contraceptives Drugs and Devices Market Forecast (2021-2025)

12.2.4 South America Contraceptives Drugs and Devices Market Forecast (2021-2025)

12.2.5 Middle East & Africa Contraceptives Drugs and Devices Market Forecast (2021-2025)

12.3 Contraceptives Drugs and Devices Market Forecast by Type (2021-2025)

12.3.1 Global Contraceptives Drugs and Devices Sales Forecast by Type (2021-2025)

12.3.2 Global Contraceptives Drugs and Devices Market Share Forecast by Type (2021-2025)

12.4 Contraceptives Drugs and Devices Market Forecast by Application (2021-2025)

12.4.1 Global Contraceptives Drugs and Devices Sales Forecast by Application (2021-2025)

12.4.2 Global Contraceptives Drugs and Devices Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Contraceptives Drugs and Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Contraceptives Drugs and Devices by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Contraceptives Drugs and Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors

Table 8. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Major Business

Table 9. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 10. Teva Pharmaceutical Industries Ltd SWOT Analysis

Table 11. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Services

Table 12. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Cooper Surgical, Inc Basic Information, Manufacturing Base and Competitors

Table 14. Cooper Surgical, Inc Contraceptives Drugs and Devices Major Business

Table 15. Cooper Surgical, Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 16. Cooper Surgical, Inc SWOT Analysis

Table 17. Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Services

Table 18. Cooper Surgical, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. Pfizer, Inc Basic Information, Manufacturing Base and Competitors

Table 20. Pfizer, Inc Contraceptives Drugs and Devices Major Business

Table 21. Pfizer, Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 22. Pfizer, Inc SWOT Analysis

Table 23. Pfizer, Inc Contraceptives Drugs and Devices Product and Services

Table 24. Pfizer, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. Church & Dwight Co. Inc Basic Information, Manufacturing Base and Competitors

Table 26. Church & Dwight Co. Inc Contraceptives Drugs and Devices Major Business

Table 27. Church & Dwight Co. Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 28. Church & Dwight Co. Inc SWOT Analysis

Table 29. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Services

Table 30. Church & Dwight Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. The Female Health Company Basic Information, Manufacturing Base and Competitors

Table 32. The Female Health Company Contraceptives Drugs and Devices Major Business

Table 33. The Female Health Company Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 34. The Female Health Company SWOT Analysis

Table 35. The Female Health Company Contraceptives Drugs and Devices Product and Services

Table 36. The Female Health Company Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. Reckitt Benckiser Plc Basic Information, Manufacturing Base and Competitors

Table 38. Reckitt Benckiser Plc Contraceptives Drugs and Devices Major Business

Table 39. Reckitt Benckiser Plc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 40. Reckitt Benckiser Plc SWOT Analysis

Table 41. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Services

Table 42. Reckitt Benckiser Plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. Cipla Limited Basic Information, Manufacturing Base and Competitors

Table 44. Cipla Limited Contraceptives Drugs and Devices Major Business

Table 45. Cipla Limited Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 46. Cipla Limited SWOT Analysis

Table 47. Cipla Limited Contraceptives Drugs and Devices Product and Services

Table 48. Cipla Limited Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. Mayer Laboratories, Inc Basic Information, Manufacturing Base and Competitors

Table 50. Mayer Laboratories, Inc Contraceptives Drugs and Devices Major Business

Table 51. Mayer Laboratories, Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 52. Mayer Laboratories, Inc SWOT Analysis

Table 53. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Services

Table 54. Mayer Laboratories, Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 55. Bayer AG Basic Information, Manufacturing Base and Competitors

Table 56. Bayer AG Contraceptives Drugs and Devices Major Business

Table 57. Bayer AG Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 58. Bayer AG SWOT Analysis

Table 59. Bayer AG Contraceptives Drugs and Devices Product and Services

Table 60. Bayer AG Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 61. Allergan plc Basic Information, Manufacturing Base and Competitors

Table 62. Allergan plc Contraceptives Drugs and Devices Major Business

Table 63. Allergan plc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 64. Allergan plc SWOT Analysis

Table 65. Allergan plc Contraceptives Drugs and Devices Product and Services

Table 66. Allergan plc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 67. Merck & Co. Inc Basic Information, Manufacturing Base and Competitors

Table 68. Merck & Co. Inc Contraceptives Drugs and Devices Major Business

Table 69. Merck & Co. Inc Contraceptives Drugs and Devices Total Revenue (USD Million) (2017-2018)

Table 70. Merck & Co. Inc SWOT Analysis

Table 71. Merck & Co. Inc Contraceptives Drugs and Devices Product and Services

Table 72. Merck & Co. Inc Contraceptives Drugs and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 73. Global Contraceptives Drugs and Devices Sales by Manufacturer (2018-2019) (K Units)

Table 74. Global Contraceptives Drugs and Devices Revenue by Manufacturer (2018-2019) (USD Million)

Table 75. Global Contraceptives Drugs and Devices Sales by Regions (2015-2020) (K Units)

Table 76. Global Contraceptives Drugs and Devices Sales Market Share by Regions (2015-2020)

Table 77. Global Contraceptives Drugs and Devices Revenue by Regions (2015-2020) (USD Million)

Table 78. North America Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)

Table 79. North America Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)

Table 80. North America Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)

Table 81. North America Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)

Table 82. Europe Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)

Table 83. Europe Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)

Table 84. Europe Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)

Table 85. Asia-Pacific Contraceptives Drugs and Devices Sales by Regions (2015-2020) (K Units)

Table 86. Asia-Pacific Contraceptives Drugs and Devices Sales Market Share by Regions (2015-2020)

Table 87. Asia-Pacific Contraceptives Drugs and Devices Revenue by Regions (2015-2020) (USD Million)

Table 88. South America Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)

Table 89. South America Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)

Table 90. South America Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)

Table 91. South America Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)

Table 92. Middle East & Africa Contraceptives Drugs and Devices Sales by Countries (2015-2020) (K Units)

Table 93. Middle East & Africa Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)

Table 94. Middle East & Africa Contraceptives Drugs and Devices Revenue by Countries (2015-2020) (USD Million)

Table 95. Middle East & Africa Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)

Table 96. Global Contraceptives Drugs and Devices Sales by Type (2015-2020) (K Units)

Table 97. Global Contraceptives Drugs and Devices Sales Share by Type (2015-2020)

Table 98. Global Contraceptives Drugs and Devices Revenue by Type (2015-2020) (USD Million)

Table 99. Global Contraceptives Drugs and Devices Revenue Share by Type (2015-2020)

Table 100. Global Contraceptives Drugs and Devices Sales by Application (2015-2020) (K Units)

Table 101. Global Contraceptives Drugs and Devices Sales Share by Application (2015-2020)

Table 102. Global Contraceptives Drugs and Devices Sales Forecast by Regions (2021-2025) (K Units)

Table 103. Global Contraceptives Drugs and Devices Market Share Forecast by Regions (2021-2025)

Table 104. Global Contraceptives Drugs and Devices Sales Forecast by Type (2021-2025) (K Units)

Table 105. Global Contraceptives Drugs and Devices Market Share Forecast by Type (2021-2025)

Table 106. Global Contraceptives Drugs and Devices Sales Forecast by Application (2021-2025)

Table 107. Global Contraceptives Drugs and Devices Market Share Forecast by Application (2021-2025)

Table 108. Direct Channel Pros & Cons

Table 109. Indirect Channel Pros & Cons

Table 110. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Contraceptives Drugs and Devices Picture

Figure 2. Global Sales Market Share of Contraceptives Drugs and Devices by Type in 2019

Figure 3. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) Picture

Figure 4. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) Picture

Figure 5. Contraceptives Drugs and Devices Sales Market Share by Application in 2018

Figure 6. Female Picture

Figure 7. Male Picture

Figure 8. Global Contraceptives Drugs and Devices Market Status and Outlook (2015-2025) (USD Million)

Figure 9. United States Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 10. Canada Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 11. Mexico Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 12. Germany Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 13. France Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 14. UK Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 15. Russia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 16. Italy Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 17. China Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 18. Japan Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 19. Korea Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 20. India Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 21. Southeast Asia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 22. Australia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 23. Brazil Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 24. Egypt Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 25. Saudi Arabia Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 26. South Africa Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 27. Turkey Contraceptives Drugs and Devices Revenue (Value) and Growth Rate (2015-2025)

Figure 28. Global Contraceptives Drugs and Devices Sales Market Share by Manufacturer in 2019

Figure 29. Global Contraceptives Drugs and Devices Revenue Market Share by Manufacturer in 2019

Figure 30. Top 3 Contraceptives Drugs and Devices Manufacturer (Revenue) Market Share in 2019

Figure 31. Top 6 Contraceptives Drugs and Devices Manufacturer (Revenue) Market Share in 2019

Figure 32. Key Manufacturer Market Share Trend

Figure 33. Global Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 34. Global Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)

Figure 35. Global Contraceptives Drugs and Devices Revenue Market Share by Regions (2015-2020)

Figure 36. Global Contraceptives Drugs and Devices Revenue Market Share by Regions in 2018

Figure 37. North America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

Figure 38. Europe Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

Figure 39. Asia-Pacific Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

Figure 40. South America Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

Figure 41. Middle East & Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020)

Figure 42. North America Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)

Figure 43. North America Contraceptives Drugs and Devices Sales Market Share by Countries (2015-2020)

Figure 44. North America Contraceptives Drugs and Devices Sales Market Share by Countries in 2018

Figure 45. North America Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 46. North America Contraceptives Drugs and Devices Revenue Market Share by Countries in 2018

Figure 47. United States Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 48. Canada Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 49. Mexico Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 50. Europe Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)

Figure 51. Europe Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)

Figure 52. Europe Contraceptives Drugs and Devices Revenue Market Share by Countries in 2019

Figure 53. Germany Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 54. UK Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 55. France Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 56. Russia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 57. Italy Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 58. Asia-Pacific Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)

Figure 59. Asia-Pacific Contraceptives Drugs and Devices Sales Market Share by Regions 2019

Figure 60. Asia-Pacific Contraceptives Drugs and Devices Revenue Market Share by Regions 2019

Figure 61. China Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 62. Japan Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 63. Korea Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 64. India Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 65. Southeast Asia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 66. South America Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)

Figure 67. South America Contraceptives Drugs and Devices Sales Market Share by Countries in 2019

Figure 68. South America Contraceptives Drugs and Devices Revenue Market Share by Countries in 2019

Figure 69. Brazil Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 70. Argentina Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 71. Middle East and Africa Contraceptives Drugs and Devices Revenue and Growth Rate (2015-2020) (USD Million)

Figure 72. Middle East and Africa Contraceptives Drugs and Devices Sales Market Share by Countries in 2019

Figure 73. Middle East and Africa Contraceptives Drugs and Devices Revenue Market Share by Countries (2015-2020)

Figure 74. Middle East and Africa Contraceptives Drugs and Devices Revenue Market Share by Countries in 2019

Figure 75. Saudi Arabia Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 76. Egypt Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 77. Turkey Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 78. South Africa Contraceptives Drugs and Devices Sales and Growth Rate (2015-2020) (K Units)

Figure 79. Global Contraceptives Drugs and Devices Sales and Growth Rate (2021-2025) (K Units)

Figure 80. Global Contraceptives Drugs and Devices Revenue and Growth Rate (2021-2025) (USD Million)

Figure 81. North America Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)

Figure 82. Europe Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)

Figure 83. Asia-Pacific Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)

Figure 84. South America Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)

Figure 85. Middle East & Africa Sales Contraceptives Drugs and Devices Market Forecast (2021-2025) (K Units)

Figure 86. Sales Channel: Direct Channel vs Indirect Channel

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

Market research helps businesses strengthen a company’s position
Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
Market research helps in identifying the potential threats and opportunities associated with the business industry
Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

Data Collection
Data Synthesis
Market Deduction & Formulation
Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends.
Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information.

We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:

Export & Import Data
Business Information related to trade and its statistics
Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.

In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
Examining demographic along with psychographic segmentation for market evaluation
Analyzing the macro and micro-economic indicators for each demography
Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology.

Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.

The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample

Full Name

Country

Phone

Company

Designation

Comment

Human Verification

Our Clients

Choose License Type

For more information

Have a Question? Email us at

sales@fiormarkets.com

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

Testimonials

Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –

Kennedy Brown
Health Technology Innovation
United States

Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance

Mika Salomäki

Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.

ONDŘEJ ŠUPKA
Analytics Department
ČESKÁ ZBROJOVKA A.S.

Dear Siddhartha,
The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us.
Thanks for all your help!